Skip to main content
. 2019 Apr 5;9(2):159–165. doi: 10.1093/jpids/piy139

Figure 1.

Figure 1.

Proportion of participants with human immunodeficiency virus type 1 (HIV-1) RNA level <400 (A) or <50 (B) copies/mL, in the intent-to-treat analysis (N = 23). Vertical bars represent 95% confidence intervals.